Latham & Watkins LLP represented the underwriters in the offering. Twist Bioscience Corporation has announced the pricing of an underwritten public offering of 2,802,272 shares of…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
